High-Intensity, Brief-Duration Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic Leukemia

NCT00002865 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Leukemia

Interventions

BIOLOGICAL: filgrastim
DRUG: cyclophosphamide
DRUG: cytarabine
DRUG: dexamethasone
DRUG: doxorubicin hydrochloride
DRUG: etoposide
DRUG: ifosfamide
DRUG: leucovorin calcium
DRUG: mesna
DRUG: methotrexate
DRUG: therapeutic hydrocortisone
DRUG: vincristine sulfate
RADIATION: low-LET cobalt-60 gamma ray therapy
RADIATION: low-LET photon therapy

Sponsor

Wake Forest University Health Sciences

Collaborators

[object Object]